Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus

OBJECTIVE: To evaluate the frequency of cell‐bound complement activation products (CB‐CAPs) as a marker of complement activation in patients with suspected systemic lupus erythematosus (SLE) and the usefulness of this biomarker as a predictor of the evolution of probable SLE into SLE as classified b...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arthritis Rheumatol
Main Authors: Ramsey‐Goldman, Rosalind, Alexander, Roberta Vezza, Massarotti, Elena M., Wallace, Daniel J., Narain, Sonali, Arriens, Cristina, Collins, Christopher E., Saxena, Amit, Putterman, Chaim, Kalunian, Kenneth C., O'Malley, Tyler, Dervieux, Thierry, Weinstein, Arthur
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Systemic Lupus Erythematosus
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6972605/
https://ncbi.nlm.nih.gov/pubmed/31469249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41093
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki